Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues

The use of patient-derived organoids (PDO) as a valuable alternative to in vivo models significantly increased over the last years in cancer research. The ability of PDOs to genetically resemble tumor heterogeneity makes them a powerful tool for personalized drug screening. Despite the extensive opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinucci, Mattia, Ercan, Caner, Taha-Mehlitz, Stephanie, Fourie, Lana, Panebianco, Federica, Bianco, Gaia, Gallon, John, Staubli, Sebastian, Soysal, Savas D., Zettl, Andreas, Rauthe, Stephan, Vosbeck, Jürg, Droeser, Raoul A., Bolli, Martin, Peterli, Ralph, von Flüe, Markus, Ng, Charlotte K. Y., Kollmar, Otto, Coto-Llerena, Mairene, Piscuoglio, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784867/
https://www.ncbi.nlm.nih.gov/pubmed/35083141
http://dx.doi.org/10.3389/fonc.2021.781833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784867/
https://www.ncbi.nlm.nih.gov/pubmed/35083141
http://dx.doi.org/10.3389/fonc.2021.781833

Ejemplares similares